NEW YORK--(BUSINESS WIRE)--Remedy Pharmaceuticals, Inc. today announced that it completed an equity financing from a new investor, Broadview Ventures, for an undisclosed amount. Funds will be used to accelerate Remedy’s GAMES-RP clinical trial of its central nervous system drug RP-1127.
Help employers find you! Check out all the jobs and post your resume.
